C9.V2 is a monoclonal antibody derived from a synthetic naive human antibody phage library, and is able to block both mouse and human P1GF binding to VEGFR1 without interfering with VEGF binding to the same receptor.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1735z | Mouse Anti-PGF Recombinant Antibody (clone 28A4) | WB, ICC, IF, IHC | Mouse IgG1 |
HPAB-0401-CN | Mouse Anti-PGF Recombinant Antibody (clone C9.V2) | WB, ELISA, Block | Mouse IgG2a, κ |
MRO-2126-CN | Rabbit Anti-PGF Polyclonal Antibody (MRO-2126-CN) | IHC, FC | Rabbit IgG |
ZG-0510U | Rabbit Anti-PGF Recombinant Antibody (clone 1B6) | ELISA, IHC | Rabbit IgG |
VS3-WK262 | Rabbit Anti-PGF Recombinant Antibody (clone JA63-15) | WB, ELISA | Rabbit IgG |
There are currently no Customer reviews or questions for HPAB-0401-CN-F(E). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.